Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03065894 · ClinicalTrials.gov registry record · NA
Risk Stratification in Primary Care Combined With Stratified-specific Physical Therapy Care for Low Back Pain
A NA study, sponsored by University of Vermont Medical Center.
- Terminated
- Registry status
- NA
- Development phase
- 90
- Enrollment target
NCT03065894: Clinical Trial NA study, sponsored by University of Vermont Medical Center.
NCT03065894 is a NA study that was terminated before completion, run by University of Vermont Medical Center. The registered enrollment target is 90 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03065894, a NA study, was terminated before completion, sponsored by University of Vermont Medical Center.
- TERMINATED
- Registry status
- NA
- Development phase
- 90 participants
- Enrollment target
Study Summary
This study aims to examine patient outcomes following risk stratification for low back pain in Family Medicine combined with either matched physical therapy (PT - i.e., stratified-specific PT) treatments or current treatment in primary care across The University of Vermont Health Network.
Primary Outcome
Low back pain disability measure
Interventions
- OTHER Matched Physical Therapy Intervention
- OTHER Current Care in Family Medicine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 90 participants |
| Start Date | 2017-03-29 |
| Est. Completion | 2018-08-31 |
| Phase | NA |
Why NCT03065894 stopped before completion
NCT03065894 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 90 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower).
The record links to 0 conditions, and to 2 interventions - of which Matched Physical Therapy Intervention is the first listed.
NCT03065894 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03065894 about?
NCT03065894 is a clinical study titled "Risk Stratification in Primary Care Combined With Stratified-specific Physical Therapy Care for Low Back Pain". This study aims to examine patient outcomes following risk stratification for low back pain in Family Medicine combined with either matched physical therapy (PT - i.e., stratified-specific PT) treatments or current treatment in primary care across The University of Vermont Health Network.
What is the current status of trial NCT03065894?
This trial is currently terminated. It is a NA study. The enrollment target is 90 participants. The study started on 2017-03-29. Estimated completion is 2018-08-31.
What interventions are being tested in trial NCT03065894?
The interventions under investigation include: Matched Physical Therapy Intervention (OTHER), Current Care in Family Medicine (OTHER).
Who is sponsoring clinical trial NCT03065894?
This trial is sponsored by University of Vermont Medical Center, which has 27 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03065894's enrollment target sits among peer trials
90 941st of 2000 higher than 1,029 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02521311 · 90 participants · Phase 2
Assessment of Clemastine Fumarate as a Remyelinating Agent in Acute Optic Neuritis (ReCOVER)
- NCT02939573 · 90 participants · Phase 2
A Randomized Multicenter Study for Isolated Skin Vasculitis
- NCT03128879 · 90 participants · Phase 2
Venetoclax With Ibrutinib or Acalabrutinib in Pts. With High-risk CLL
- NCT03184038 · 90 participants · NA
Neurocognition in Patients With Multiple Brain Metastases Treated With Radiosurgery
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI